2023 Medical Devices CE Mark for a MDSW (Medical Device Software)

REPHINE SPEECH MARKS OPEN MEDICALDEVICES

The company obtained CE marking in less time thanks to Rephine’s global approach to ensure not only the development and validation of the software but also the necessary quality assurance system (QMS).

REPHINE SPEECH MARKS CLOSE MEDICALDEVICES

About this Case Study

The case study involved CE Mark for a new Medical Device Software. The company has developed software that is considered as a Medical Device. They must comply with the regulatory requirements and obtain the CE Mark for the
commercialisation of the new product in Europe.

To learn more about the successful project and the comprehensive results achieved in obtaining CE Mark compliance, download the full case study now.

Discover the step-by-step process, key improvements, and valuable insights that led to the company obtaining CE mark in a shorter time period.

Download the Case Study

View other our other resources and company news

GMP Raising the bar Blog series Header image May 25 Blog

Building Resilient Pharmaceutical Supplier Ecosystems

In today's volatile landscape, traditional supplier qualification is no longer enough. Learn how pharma companies can build resilient supplier ecosystems through risk-based strategies, real-time monitoring, ...
Read More
CPV Header image blog apr 25 Blog

IT Quality Assurance in Pharma: Ensuring Compliance, Validation & Data Integrity

IT Quality Assurance plays a pivotal role in the life sciences sector, ensuring systems are validated, compliant, and audit-ready. Learn how pharma companies can meet ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

IT Quality Assurance in Pharma: Ensuring Compliance, Validation & Data Integrity

Artificial intelligence and data analytics are reshaping pharmaceutical GMP compliance—but not all innovations are audit-ready. This article explores proven AI use cases, regulator expectations, and ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Risk-Based Auditing: Smarter GxP Compliance with Limited Resources

In today’s pharma landscape, risk-based auditing enables smarter supplier oversight by aligning audit efforts with risk. Discover the benefits, regulatory backing, and how Rephine helps ...
Read More
Pharma equipment qualification hero image Case Study

Pharmaceutical Equipment Requalification Case Study

See how Rephine helped a global pharma company streamline equipment requalification across complex sites with a scalable, risk-based approach aligned with Annex 15.
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Continuous Inspection Readiness Beyond Mock Audits

Traditional mock audits aren’t enough. With rising unannounced inspections, pharmaceutical and biotech firms must embrace continuous inspection readiness. This article explores how to embed compliance ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

How Rephine Accelerates Digital QMS Transformation in Pharma

Rephine helps pharmaceutical and biotech companies transition to digital QMS platforms like Veeva Vault, MasterControl, or TrackWise. From vendor-neutral selection to full GxP-compliant validation and ...
Read More
CPV Header image blog apr 25 Blog

Threat Modelling in Medical Devices: STRIDE for MDR/IVDR Cybersecurity Compliance

Understand how STRIDE and other threat modelling techniques help medical device manufacturers meet MDR/IVDR cybersecurity requirements—plus real-world examples and expert insights.
Read More
Medical Device Guide

Security Risk Management for Medical Devices: MDR & IVDR Compliance Whitepaper

Understand how to embed cybersecurity into the medical device lifecycle with this expert guide from Rephine. Includes MDR/IVDR, FDA, and IMDRF guidance on SRM, threat ...
Read More
Contact Us